Adamis Pharmaceuticals PE Ratio 2006-2019 | ADMP

Current and historical p/e ratio for Adamis Pharmaceuticals (ADMP) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Adamis Pharmaceuticals PE ratio as of April 03, 2020 is 0.00.
Adamis Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-04-03 0.34 0.00
2019-12-31 0.70 $-0.47 0.00
2019-09-30 0.70 $-0.75 0.00
2019-06-30 1.30 $-0.84 0.00
2019-03-31 2.11 $-0.97 0.00
2018-12-31 2.25 $-1.01 0.00
2018-09-30 3.50 $-0.97 0.00
2018-06-30 3.20 $-0.97 0.00
2018-03-31 3.50 $-0.87 0.00
2017-12-31 4.40 $-0.90 0.00
2017-09-30 5.23 $-0.66 0.00
2017-06-30 5.20 $-0.86 0.00
2017-03-31 4.25 $-1.04 0.00
2016-12-31 3.15 $-1.26 0.00
2016-09-30 3.43 $-1.47 0.00
2016-06-30 2.80 $-1.30 0.00
2016-03-31 6.13 $-1.20 0.00
2015-12-31 5.40 $-1.04 0.00
2015-09-30 3.87 $-0.83 0.00
2015-06-30 4.20 $-0.79 0.00
2015-03-31 3.94 $-0.79 0.00
2014-12-31 6.17 $-0.65 0.00
2014-09-30 4.68 $-1.47 0.00
2014-06-30 4.81 $-1.28 0.00
2014-03-31 6.36 $-1.18 0.00
2013-12-31 6.39 $-1.00 0.00
2013-09-30 6.38 $-0.18 0.00
2013-06-30 11.22 $-0.17 0.00
2013-03-31 11.22 0 0.00
2012-12-31 12.07 0 0.00
2012-09-30 10.03 $-0.17 0.00
2012-06-30 12.41 $-0.51 0.00
2012-03-31 3.91 $-0.85 0.00
2011-12-31 2.89 $-0.85 0.00
2011-09-30 3.57 $-3.06 0.00
2011-06-30 3.74 $-3.57 0.00
2011-03-31 3.16 $-3.91 0.00
2010-12-31 3.66 $-3.91 0.00
2010-09-30 3.74 $-2.04 0.00
2010-06-30 4.42 $-1.53 0.00
2010-03-31 3.57 $-1.19 0.00
2009-12-31 5.44 $-1.36 0.00
2009-09-30 4.59 $-1.02 0.00
2009-06-30 2.98 $-0.85 0.00
2009-03-31 11.82 $-0.68 0.00
2008-12-31 6.75 $-0.85 0.00
2008-09-30 6.75 $-1.02 0.00
2008-06-30 11.82 $-2.54 0.00
2008-03-31 8.44 $-5.75 0.00
2007-12-31 8.44 $-8.78 0.00
2007-09-30 10.13 $-8.44 0.00
2007-06-30 15.19 $-15.26 0.00
2007-03-31 16.88 $-18.68 0.00
2006-12-31 10.13 $-28.74 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.023B $0.022B
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.107B 31.88
Takeda Pharmaceutical (TAK) Japan $46.440B 8.14
Astellas Pharma (ALPMY) Japan $28.068B 14.02
Eisai (ESALY) Japan $19.576B 36.47
UCB SA (UCBJF) Belgium $16.930B 0.00
Grifols, S.A (GRFS) Spain $13.607B 16.92
Merck (MKGAF) Germany $12.536B 16.44
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.966B 221.31
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.312B 30.08
Ionis Pharmaceuticals (IONS) United States $6.823B 20.68
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.361B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.587B 6.81
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.596B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.105B 0.00
Hypermarcas (HYPMY) Brazil $3.434B 10.44
Evotec AG (EVTCY) Germany $3.422B 55.18
Nektar Therapeutics (NKTR) United States $3.033B 0.00
FibroGen (FGEN) United States $2.996B 0.00
PTC Therapeutics (PTCT) United States $2.816B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.736B 50.77
ChemoCentryx (CCXI) United States $2.450B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.387B 9.66
Xencor (XNCR) United States $1.697B 69.30
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.613B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.598B 19.42
Theravance Biopharma (TBPH) Cayman Islands $1.397B 0.00
Sage Therapeutics (SAGE) United States $1.389B 0.00
Corcept Therapeutics (CORT) United States $1.375B 15.39
Pacira Pharmaceuticals (PCRX) United States $1.369B 37.45
USANA Health Sciences (USNA) United States $1.352B 14.19
Karyopharm Therapeutics (KPTI) United States $1.186B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Zogenix (ZGNX) United States $1.052B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.996B 30.85
Akebia Therapeutics (AKBA) United States $0.918B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.913B 12.71
Esperion Therapeutics (ESPR) United States $0.907B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
Endo (ENDP) Ireland $0.701B 1.29
Tilray (TLRY) Canada $0.635B 0.00
Aerie Pharmaceuticals (AERI) United States $0.607B 0.00
ImmunoGen (IMGN) United States $0.605B 0.00
Molecular Templates (MTEM) United States $0.584B 0.00
Radius Health (RDUS) United States $0.579B 0.00
Portola Pharmaceuticals (PTLA) United States $0.557B 0.00
Translate Bio (TBIO) United States $0.546B 0.00
Collegium Pharmaceutical (COLL) United States $0.536B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.410B 16.85
Indivior (INVVY) United States $0.389B 2.31
Siga Technologies (SIGA) United States $0.388B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.379B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.374B 12.48
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.344B 0.00
Organogenesis Holdings (ORGO) United States $0.313B 0.00
Trillium Therapeutics (TRIL) Canada $0.308B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Calithera Biosciences (CALA) United States $0.284B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
DURECT (DRRX) United States $0.280B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.272B 0.00
TherapeuticsMD (TXMD) United States $0.271B 0.00
Lannett Co Inc (LCI) United States $0.267B 4.31
Flexion Therapeutics (FLXN) United States $0.264B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.255B 0.00
Ocular Therapeutix (OCUL) United States $0.250B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Concert Pharmaceuticals (CNCE) United States $0.231B 0.00
OptiNose (OPTN) United States $0.192B 0.00
CASI Pharmaceuticals (CASI) United States $0.190B 0.00
Rafael Holdings (RFL) United States $0.189B 0.00
Recro Pharma (REPH) United States $0.168B 0.00
PROFOUND MEDICL (PROF) Canada $0.155B 0.00
MEI Pharma (MEIP) United States $0.154B 0.00
Jounce Therapeutics (JNCE) United States $0.152B 2.74
Nature's Sunshine Products (NATR) United States $0.148B 18.58
La Jolla Pharmaceutical (LJPC) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.133B 0.00
KalVista Pharmaceuticals (KALV) United States $0.133B 0.00
VAXART, INC (VXRT) United States $0.119B 0.00
Redhill Biopharma (RDHL) Israel $0.114B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.109B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.092B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.087B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
IMV INC (IMV) Canada $0.080B 0.00
Hemispherx BioPharma (AIM) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.071B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Biomerica (BMRA) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Aquestive Therapeutics (AQST) United States $0.063B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Xeris Pharmaceuticals (XERS) United States $0.059B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.055B 17.19
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.052B 0.00
CV Sciences (CVSI) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.047B 0.00
PharmAthene (ALT) United States $0.046B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
Infinity Pharmaceuticals (INFI) United States $0.044B 0.00
Natural Alternatives (NAII) United States $0.044B 19.84
Sundial Growers (SNDL) Canada $0.041B 0.00
MediWound (MDWD) Israel $0.041B 0.00
GTx (ONCT) United States $0.040B 0.00
PolarityTE (PTE) United States $0.038B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 128.71
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
IsoRay (ISR) United States $0.036B 0.00
Forward Pharma (FWP) Denmark $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
Mannatechorporated (MTEX) United States $0.025B 7.79
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.022B 0.00
ElectroCore (ECOR) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Novan (NOVN) United States $0.020B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
KemPharm (KMPH) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00